Endothelial dysfunction and its critical role in COVID-19-associated coagulopathy: Defibrotide as an endothelium-protective, targeted therapy.
作者信息
García-Bernal David, Richardson Edward, Vlodavsky Israel, Carlo-Stella Carmelo, Iacobelli Massimo, Jara Rubén, Richardson Paul G, Moraleda Jose M
机构信息
Department of Medicine Hematopoietic Transplant and Cellular Therapy Unit IMIB-Arrixaca Virgen de la Arrixaca University Hospital University of Murcia Murcia Spain.
Frank H. Netter M.D. School of Medicine Quinnipiac University North Haven Connecticut USA.
出版信息
EJHaem. 2021 Jun 22;2(3):680-681. doi: 10.1002/jha2.198. eCollection 2021 Aug.
Abstract
摘要
相似文献
1
Endothelial dysfunction and its critical role in COVID-19-associated coagulopathy: Defibrotide as an endothelium-protective, targeted therapy.
EJHaem. 2021 Jun 22;2(3):680-681. doi: 10.1002/jha2.198. eCollection 2021 Aug.
2
Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide.
medRxiv. 2021 Jul 15:2021.02.21.21252160. doi: 10.1101/2021.02.21.21252160.
3
Novel beneficial mechanisms of defibrotide, a prostacyclin enhancing agent in splanchnic artery occlusion and reperfusion in rats.
Methods Find Exp Clin Pharmacol. 1991 Dec;13(10):667-74.
4
Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide.
JCI Insight. 2021 Sep 8;6(17):e149149. doi: 10.1172/jci.insight.149149.
5
Chronic oral defibrotide counteracts hypercholesterolemia noxious effects on cardiovascular function in the rabbit.
Thromb Res. 1999 Jun 1;94(5):327-38. doi: 10.1016/s0049-3848(99)00009-2.
6
Coronary endothelium-protective effects of defibrotide in ischaemia and reperfusion.
Naunyn Schmiedebergs Arch Pharmacol. 1990 Mar;341(3):246-50. doi: 10.1007/BF00169738.
7
The use of defibrotide in blood and marrow transplantation.
Blood Adv. 2018 Jun 26;2(12):1495-1509. doi: 10.1182/bloodadvances.2017008375.
8
Protective effect of defibrotide on perfusion induced endothelial damage.
Thromb Res. 2000 Aug 15;99(4):335-41. doi: 10.1016/s0049-3848(00)00256-5.
9
Acute Graft-vs.-Host Disease-Associated Endothelial Activation Is Prevented by Defibrotide.
Front Immunol. 2019 Oct 9;10:2339. doi: 10.3389/fimmu.2019.02339. eCollection 2019.
10
Possible role of defibrotide in endothelial cell protection.
Int J Tissue React. 1993;15(4):157-61.
引用本文的文献
1
Defibrotide for Protecting Against and Managing Endothelial Injury in Hematologic Malignancies and COVID-19.
Biomolecules. 2025 Jul 14;15(7):1004. doi: 10.3390/biom15071004.
2
Endothelial activation and damage as a common pathological substrate in different pathologies and cell therapy complications.
Front Med (Lausanne). 2023 Nov 14;10:1285898. doi: 10.3389/fmed.2023.1285898. eCollection 2023.
3
Defibrotide Therapy for SARS-CoV-2 ARDS.
Chest. 2022 Aug;162(2):346-355. doi: 10.1016/j.chest.2022.03.046. Epub 2022 Apr 9.
本文引用的文献
1
COVID-19 coagulopathy: is it disseminated intravascular coagulation?
Intern Emerg Med. 2021 Mar;16(2):309-312. doi: 10.1007/s11739-020-02601-y. Epub 2020 Dec 24.
2
Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients.
EBioMedicine. 2020 Sep;59:102969. doi: 10.1016/j.ebiom.2020.102969. Epub 2020 Aug 25.
3
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.
Lancet Haematol. 2020 Aug;7(8):e575-e582. doi: 10.1016/S2352-3026(20)30216-7. Epub 2020 Jun 30.
4
Defibrotide inhibits donor leucocyte-endothelial interactions and protects against acute graft-versus-host disease.
J Cell Mol Med. 2020 Jul;24(14):8031-8044. doi: 10.1111/jcmm.15434. Epub 2020 Jun 10.
5
Heparanase, cell signaling, and viral infections.
Cell Mol Life Sci. 2020 Dec;77(24):5059-5077. doi: 10.1007/s00018-020-03559-y. Epub 2020 May 27.
6
Endothelial cell infection and endotheliitis in COVID-19.
Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.
7
Hematological findings and complications of COVID-19.
Am J Hematol. 2020 Jul;95(7):834-847. doi: 10.1002/ajh.25829. Epub 2020 May 23.
8
The use of defibrotide in blood and marrow transplantation.
Blood Adv. 2018 Jun 26;2(12):1495-1509. doi: 10.1182/bloodadvances.2017008375.
9
Preclinical studies in support of defibrotide for the treatment of multiple myeloma and other neoplasias.
Clin Cancer Res. 2009 Feb 15;15(4):1210-21. doi: 10.1158/1078-0432.CCR-08-1270.
Zotero 插件